@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:result . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T20:04:36.146972"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "in inhibition of spike glycoprotein S1-induced NF-κB activation" . rdf:OBJECT-POSITION rdfs:label "143"^^xsd:integer . rdf:PREDICATE rdfs:label "resulted" . rdf:PREDICATE-POSITION rdfs:label "[111]" . rdf:SUBJECT rdfs:label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" . rdf:SUBJECT-POSITION rdfs:label "12"^^xsd:integer . rdfs:ABSTRACT-UID ns3:50 "z9oyrkzt" . rdfs:SENTENCE rdfs:label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." . rdfs:TRIPLE-UID ns2:z9oyrkzt-TRIPLE-ABSTRACT-2 "z9oyrkzt-TRIPLE-ABSTRACT-2" . rdfs:label "glycoprotein" . rdfs:label "human" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "Y3/cXj0HeYxtCBmfx3QL6dh0DKPCHWv3bApONeUtiPuSkllDWIh6EQykoiTmPh7OFtGayDFKw5hYXX7zgsBIe0n+/aax+PM+2sQvuJQMndiyKJX1bMICuE6sPAkq7nz3XyiiS6WC87x/7cg4FpPWOOtifmaoaPazQPXh3bq3/JM="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T20:04:36.146972"^^xsd:dateTime; prov:wasAttributedTo . }